Why Galera Therapeutics (GRTX) Stock Is Nosediving
Why Galera Therapeutics (GRTX) Stock Is Nosediving
Galera Therapeutics Inc (NASDAQ:GRTX) shares are trading lower by 34.8% to $0.14 during Monday's session after the company received a notice from Nasdaq's Office of General Counsel stating that the Nasdaq Hearings Panel decided to delist the company's shares due to non-compliance with Nasdaq's continued listing standards.
Galera therapeutics公司（纳斯达克代码：GRTX）的股票在周一交易时下跌了34.8％，至0.14美元，因为该公司收到了纳斯达克总法律顾问办公室的通知，称纳斯达克听证会决定将公司股票从纳斯达克股票市场摘牌，因为公司未能符合纳斯达克股票市场的继续上市标准。
The company failed to meet the minimum average market value of listed securities, the minimum bid price, and the minimum market value of publicly held shares. As a result, trading of the company's shares will be suspended on Nasdaq starting June 4, 2024.
该公司未达到上市证券最低平均市值、最低买入价和公开持股市值最低标准。因此，该公司的股票交易将从2024年6月4日起在纳斯达克停牌。
Galera Therapeutics plans for its shares to be quoted on the OTC Markets Group under the symbol "GRTX" following the suspension. The company says it retains the right to request a review of the delisting decision.
随着停牌，Galera therapeutics计划在场外市场集团（OTC Markets Group）通过标的为“GRTX”的名称引用其股票。该公司表示，保留请求审查摘牌决定的权利。
According to data from Benzinga Pro, GRTX has a 52-week high of $3.59 and a 52-week low of $0.08.
根据Benzinga Pro的数据，GRTX股票52周最高价为$3.59，52周最低价为$0.08。